Multikine: Phase II trial update

By WIR Staff | Feb 1, 1999 | 8:00 AM GMT

Cel-Sci Corp. (HIV; Berlin:LSR), Vienna, Va.
Product: Multikine
Business: Cancer
Therapeutic